• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T cell recognition of a point mutation in the P21 Ras protein.

作者信息

Yin L, Lowe P, Stauss H J

机构信息

Human Tumour Immunology group, Imperial Cancer Research Fund, University College London, UK.

出版信息

Leukemia. 1993 Aug;7 Suppl 2:S27-30.

PMID:7689674
Abstract

Point mutations of p21 Ras proteins correlate with many human malignancies. To determine whether the mutations of Ras proteins generate immunogenic determinants which can be recognized by T cells and possibly serve as targets for immunotherapy, we studied the murine T helper responses to synthetic Ras peptides corresponding to amino acids 1-23 of normal or mutant Ras protein. Immunization of C3H/He and B10.BR mice with Ras peptides containing a valine mutation at position 12 stimulated MHC class II-restricted T helper cells which recognised specifically the Ras mutation. Surprisingly C57BL/10 mice generated T helper responses not only against mutant but also against normal Ras peptides. Importantly, natural processing of Ras protein was found to generate the epitopes recognized by the peptide-induced T cells.

摘要

相似文献

1
T cell recognition of a point mutation in the P21 Ras protein.
Leukemia. 1993 Aug;7 Suppl 2:S27-30.
2
Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21.针对携带K-ras p21突变表位的肿瘤细胞的细胞溶解性CD4+ T淋巴细胞的肽特异性激活。
Eur J Immunol. 1995 Sep;25(9):2588-97. doi: 10.1002/eji.1830250928.
3
Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.鉴定激活CD4+和CD8+ T细胞反应的突变型ras癌基因肽中的重叠表位。
Eur J Immunol. 1996 Feb;26(2):435-43. doi: 10.1002/eji.1830260225.
4
T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.T细胞对由突变的ras原癌基因编码的转化蛋白的识别。
J Immunol. 1991 Mar 15;146(6):2059-65.
5
Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.从用反映第12密码子突变的ras癌基因衍生肽免疫的患者中生成稳定的CD4 +和CD8 + T细胞系。
Cell Immunol. 1997 Dec 15;182(2):137-51. doi: 10.1006/cimm.1997.1224.
6
Mutant ras epitopes as targets for cancer vaccines.突变型ras表位作为癌症疫苗的靶点。
Semin Oncol. 1996 Feb;23(1):118-34.
7
Comparison of linear and branched peptide forms (MAPs) in the induction of T helper responses to point-mutated ras immunogens.线性肽与分支肽形式(多抗原肽,MAPs)在诱导针对点突变型ras免疫原的T辅助细胞应答中的比较。
Cell Immunol. 1996 Dec 15;174(2):199-209. doi: 10.1006/cimm.1996.0310.
8
Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells.包含p21 ras中一个点突变(12甘氨酸→精氨酸)的重叠表位可被HLA - DR、- DP和 - DQ限制性T细胞识别。
Eur J Immunol. 1993 Oct;23(10):2687-91. doi: 10.1002/eji.1830231045.
9
Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.包含“混杂”T细胞表位的肽疫苗可绕过某些单倍型受限的免疫反应,并提供广谱免疫原性。
J Mol Recognit. 1993 Jun;6(2):81-94. doi: 10.1002/jmr.300060206.
10
Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein.在Ras蛋白中鉴定出两个细胞毒性T淋巴细胞识别表位。
J Exp Med. 1993 May 1;177(5):1493-8. doi: 10.1084/jem.177.5.1493.